HALO Insider Trading

Insider Ownership Percentage: 2.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,666,350.00

Halozyme Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Halozyme Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Halozyme Therapeutics Share Price & Price History

Current Price: $51.84
Price Change: Price Decrease of -0.81 (-1.54%)
As of 02/6/2023 05:31 PM ET

This chart shows the closing price history over time for HALO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Halozyme Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/19/2023Helen TorleyCEOSell10,000$52.41$524,100.00587,177View SEC Filing Icon  
1/17/2023Michael J. LaBarreSVPSell10,000$50.46$504,600.00143,137View SEC Filing Icon  
12/15/2022Helen TorleyCEOSell10,000$57.37$573,700.00587,177View SEC Filing Icon  
12/13/2022Michael J. LaBarreSVPSell10,000$58.67$586,700.00153,137View SEC Filing Icon  
12/5/2022Matthew L PosardDirectorSell10,000$55.74$557,400.00115,189View SEC Filing Icon  
12/2/2022Matthew L PosardDirectorSell10,000$58.80$588,000.00125,189View SEC Filing Icon  
11/17/2022Helen TorleyCEOSell10,000$52.15$521,500.00587,177View SEC Filing Icon  
11/15/2022Michael J. LaBarreSVPSell10,000$54.13$541,300.00163,137View SEC Filing Icon  
11/15/2022Nicole LabrosseCFOSell5,000$53.81$269,050.004,045View SEC Filing Icon  
11/8/2021Helen TorleyCEOSell50,000$39.82$1,991,000.00View SEC Filing Icon  
11/5/2021Connie MatsuiDirectorSell32,000$40.38$1,292,160.00View SEC Filing Icon  
10/4/2021Helen TorleyCEOSell50,000$40.09$2,004,500.00View SEC Filing Icon  
10/1/2021Michael J. LaBarreSVPSell29,450$39.93$1,175,938.50View SEC Filing Icon  
9/7/2021Helen TorleyCEOSell50,000$42.38$2,119,000.00587,160View SEC Filing Icon  
8/25/2021Jean-Pierre BizzariDirectorSell35,000$41.01$1,435,350.00View SEC Filing Icon  
8/10/2021Helen TorleyCEOSell50,000$41.11$2,055,500.00View SEC Filing Icon  
7/6/2021Helen TorleyCEOSell50,000$45.97$2,298,500.00587,160View SEC Filing Icon  
7/1/2021Michael J. LaBarreSVPSell40,315$45.70$1,842,395.50View SEC Filing Icon  
6/7/2021Helen TorleyCEOSell50,000$39.66$1,983,000.00587,160View SEC Filing Icon  
5/11/2021Helen TorleyCEOSell50,000$43.02$2,151,000.00587,160View SEC Filing Icon  
4/14/2021Kenneth J. KelleyDirectorSell5,000$45.00$225,000.00179,833View SEC Filing Icon  
4/5/2021Helen TorleyCEOSell50,000$42.55$2,127,500.00587,160View SEC Filing Icon  
4/1/2021Michael J. LaBarreSVPSell28,689$42.56$1,221,003.84
3/1/2021Helen TorleyCEOSell50,000$46.19$2,309,500.00587,160View SEC Filing Icon  
3/1/2021Kenneth J. KelleyDirectorSell5,000$45.34$226,700.00185,333View SEC Filing Icon  
3/1/2021Michael J. LaBarreSVPSell18,324$45.81$839,422.44129,330View SEC Filing Icon  
2/1/2021Helen TorleyCEOSell50,000$47.84$2,392,000.00520,522View SEC Filing Icon  
2/1/2021Kenneth J. KelleyDirectorSell5,000$48.12$240,600.00190,079View SEC Filing Icon  
1/4/2021Kenneth J. KelleyDirectorSell5,000$42.91$214,550.00195,123View SEC Filing Icon  
12/21/2020Michael J. LaBarreSVPSell12,000$42.58$510,960.00123,400View SEC Filing Icon  
12/7/2020Kenneth J. KelleyDirectorSell35,086$41.00$1,438,526.00199,833View SEC Filing Icon  
12/2/2020Kenneth J. KelleyDirectorSell31,792$41.00$1,303,472.00234,919View SEC Filing Icon  
11/27/2020Kenneth J. KelleyDirectorSell10,000$41.25$412,500.00276,711View SEC Filing Icon  
11/25/2020Helen TorleyCEOSell50,000$40.73$2,036,500.00530,522View SEC Filing Icon  
11/25/2020Jeffrey William HendersonDirectorSell24,498$40.08$981,879.8447,609View SEC Filing Icon  
11/20/2020Michael J. LaBarreSVPSell12,000$38.76$465,120.00142,689View SEC Filing Icon  
10/20/2020Michael J. LaBarreSVPSell12,000$30.43$365,160.00146,800View SEC Filing Icon  
9/21/2020Michael J. LaBarreSVPSell12,000$26.91$322,920.00158,800View SEC Filing Icon  
9/11/2020Connie MatsuiDirectorSell32,000$27.06$865,920.00216,753View SEC Filing Icon  
8/20/2020Michael J. LaBarreSVPSell12,000$28.30$339,600.00170,800View SEC Filing Icon  
8/13/2020James M. DalyDirectorSell34,337$29.12$999,893.4431,365View SEC Filing Icon  
7/20/2020Michael J. LaBarreSVPSell12,000$29.01$348,120.00182,800View SEC Filing Icon  
5/20/2020Michael J. LaBarreSVPSell21,387$23.80$509,010.60197,574View SEC Filing Icon  
3/19/2020Kenneth J. KelleyDirectorBuy52,629$14.23$748,910.67242,467View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Halozyme Therapeutics (NASDAQ:HALO)

96.32% of Halozyme Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HALO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Halozyme Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/6/2023Ifrah Financial Services Inc.6,751$0.38M0.1%-3.9%0.005%Search for SEC Filing on Google Icon
2/6/2023Retirement Systems of Alabama178,214$10.14M0.0%-1.2%0.132%Search for SEC Filing on Google Icon
2/6/2023Pacer Advisors Inc.25,916$1.48M0.0%+339.6%0.019%Search for SEC Filing on Google Icon
2/6/2023Synovus Financial Corp78,875$4.49M0.1%+2.5%0.058%Search for SEC Filing on Google Icon
2/6/2023Los Angeles Capital Management LLC152,388$8.67M0.0%-15.9%0.113%Search for SEC Filing on Google Icon
2/6/2023Harvest Fund Management Co. Ltd1,002$57K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/6/2023Lisanti Capital Growth LLC147,320$8.38M1.1%N/A0.109%Search for SEC Filing on Google Icon
2/3/2023Pzena Investment Management LLC14,507$0.83M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/3/2023Birchview Capital LP10,000$0.57M0.4%N/A0.007%Search for SEC Filing on Google Icon
2/3/2023EFG Asset Management North America Corp.124,572$7.10M1.6%-17.4%0.092%Search for SEC Filing on Google Icon
2/3/2023Fisher Asset Management LLC435,917$24.80M0.0%-36.7%0.322%Search for SEC Filing on Google Icon
2/3/2023Mizuho Markets Americas LLC275,268$15.66M0.9%-23.3%0.204%Search for SEC Filing on Google Icon
2/2/2023SG Americas Securities LLC49,932$2.84M0.0%-24.6%0.037%Search for SEC Filing on Google Icon
2/2/2023Kornitzer Capital Management Inc. KS305,349$17.37M0.4%-31.8%0.226%Search for SEC Filing on Google Icon
2/2/2023ProShare Advisors LLC38,700$2.20M0.0%+6.8%0.029%Search for SEC Filing on Google Icon
2/2/2023HighMark Wealth Management LLC41,790$2.38M1.8%-13.8%0.031%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can315,973$18.59M0.0%-26.8%0.234%Search for SEC Filing on Google Icon
2/1/2023Meritage Portfolio Management198,041$11.27M0.9%-3.2%0.146%Search for SEC Filing on Google Icon
2/1/2023Zurcher Kantonalbank Zurich Cantonalbank 20,206$1.15M0.0%+8.7%0.015%Search for SEC Filing on Google Icon
2/1/2023Janney Montgomery Scott LLC8,290$0.47M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/1/2023Tran Capital Management L.P.1,084,118$61.69M7.8%-4.8%0.802%Search for SEC Filing on Google Icon
2/1/2023Vahanian & Associates Financial Planning Inc.9,225$0.53M1.7%N/A0.007%Search for SEC Filing on Google Icon
1/31/2023Kestra Advisory Services LLC5,285$0.30M0.0%N/A0.004%Search for SEC Filing on Google Icon
1/31/2023Cookson Peirce & Co. Inc.46,272$2.63M0.2%-9.1%0.034%Search for SEC Filing on Google Icon
1/31/2023China Universal Asset Management Co. Ltd.21,636$1.23M0.5%-13.2%0.016%Search for SEC Filing on Google Icon
1/31/2023Cabot Wealth Management Inc.49,226$2.80M0.5%+50.8%0.036%Search for SEC Filing on Google Icon
1/31/2023Knights of Columbus Asset Advisors LLC74,707$4.25M0.4%-17.6%0.055%Search for SEC Filing on Google Icon
1/31/2023Geneos Wealth Management Inc.4,550$0.26M0.0%+15.2%0.003%Search for SEC Filing on Google Icon
1/27/2023Natixis Advisors L.P.50,789$2.89M0.0%+19.1%0.038%Search for SEC Filing on Google Icon
1/27/2023State of Michigan Retirement System34,438$1.96M0.0%-0.9%0.025%Search for SEC Filing on Google Icon
1/27/2023Arbor Investment Advisors LLC17,950$1.02M0.2%N/A0.013%Search for SEC Filing on Google Icon
1/26/2023Comerica Bank62,557$3.19M0.0%-3.0%0.046%Search for SEC Filing on Google Icon
1/26/2023Stephens Investment Management Group LLC1,294,025$73.73M1.3%-0.4%0.957%Search for SEC Filing on Google Icon
1/26/2023Inspire Investing LLC4,131$0.24M0.0%-20.6%0.003%Search for SEC Filing on Google Icon
1/26/2023Strs Ohio26,500$1.51M0.0%-39.8%0.020%Search for SEC Filing on Google Icon
1/26/2023Dupont Capital Management Corp10,644$0.61M0.0%+3.7%0.008%Search for SEC Filing on Google Icon
1/25/2023MGO One Seven LLC11,033$0.63M0.1%-2.9%0.008%Search for SEC Filing on Google Icon
1/25/2023Fifth Third Bancorp12,885$0.73M0.0%-8.2%0.010%Search for SEC Filing on Google Icon
1/25/2023Lindbrook Capital LLC1,906$0.11M0.0%-14.8%0.001%Search for SEC Filing on Google Icon
1/24/2023Oak Ridge Investments LLC93,066$5.30M0.8%-2.2%0.069%Search for SEC Filing on Google Icon
1/24/2023Louisiana State Employees Retirement System36,200$2.06M0.1%-1.4%0.027%Search for SEC Filing on Google Icon
1/24/2023Park Avenue Securities LLC7,668$0.44M0.0%+16.3%0.006%Search for SEC Filing on Google Icon
1/24/2023Centerpoint Advisors LLC700$40K0.0%-33.3%0.001%Search for SEC Filing on Google Icon
1/24/2023Xponance Inc.20,868$1.19M0.0%-2.3%0.015%Search for SEC Filing on Google Icon
1/23/2023Allspring Global Investments Holdings LLC398,216$22.66M0.0%-46.5%0.295%Search for SEC Filing on Google Icon
1/23/2023Scout Investments Inc.284,744$16.20M0.3%-4.9%0.211%Search for SEC Filing on Google Icon
1/23/2023Verdence Capital Advisors LLC14,762$0.84M0.1%-5.8%0.011%Search for SEC Filing on Google Icon
1/20/2023Edmonds Duncan Registered Investment Advisors LLC3,849$0.22M0.1%N/A0.003%Search for SEC Filing on Google Icon
1/20/2023Redwood Investments LLC441,809$25.14M3.4%-1.0%0.327%Search for SEC Filing on Google Icon
1/19/2023Crossmark Global Holdings Inc.18,928$1.08M0.0%-18.1%0.014%Search for SEC Filing on Google Icon
1/18/2023Bernzott Capital Advisors444,728$25.31M3.3%-2.4%0.329%Search for SEC Filing on Google Icon
1/18/2023Private Advisor Group LLC21,717$1.22B0.1%-48.0%0.016%Search for SEC Filing on Google Icon
1/17/2023Tealwood Asset Management Inc.26,249$1.49M0.8%-8.1%0.019%Search for SEC Filing on Google Icon
1/13/2023Cooper Financial Group7,378$0.42M0.1%+6.3%0.005%Search for SEC Filing on Google Icon
1/12/2023Titleist Asset Management LTD.4,794$0.27M0.1%N/A0.004%Search for SEC Filing on Google Icon
1/12/2023First Hawaiian Bank27,285$1.55M0.1%-14.6%0.020%Search for SEC Filing on Google Icon
1/12/2023Assenagon Asset Management S.A.158,671$9.03M0.0%+1,038.6%0.117%Search for SEC Filing on Google Icon
1/10/2023Coldstream Capital Management Inc.4,930$0.28M0.0%N/A0.004%Search for SEC Filing on Google Icon
1/9/2023Yousif Capital Management LLC71,948$4.09M0.1%+1.7%0.053%Search for SEC Filing on Google Icon
12/22/2022Bernzott Capital Advisors455,583$18.01M2.5%+22.2%0.337%Search for SEC Filing on Google Icon
12/9/2022Penn Capital Management Company LLC315,584$12.53M1.4%+5.3%0.233%Search for SEC Filing on Google Icon
11/22/2022Teachers Retirement System of The State of Kentucky26,090$1.03M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/21/2022California State Teachers Retirement System180,054$7.12M0.0%-1.0%0.133%Search for SEC Filing on Google Icon
11/17/2022M&T Bank Corp101,277$4.01M0.0%-1.0%0.075%Search for SEC Filing on Google Icon
11/16/2022Glenmede Trust Co. NA384,599$15.21M0.1%-10.8%0.284%Search for SEC Filing on Google Icon
11/16/2022Advisory Research Inc.37,915$1.50M0.1%+6.6%0.028%Search for SEC Filing on Google Icon
11/16/2022Almanack Investment Partners LLC.1,382$55K0.0%N/A0.001%Search for SEC Filing on Google Icon
11/16/2022Alpha Paradigm Partners LLC23,099$0.91M0.4%N/A0.017%Search for SEC Filing on Google Icon
11/16/2022Balyasny Asset Management LLC119,406$4.72M0.0%N/A0.088%Search for SEC Filing on Google Icon
11/16/2022Baird Financial Group Inc.72,114$2.85M0.0%+2.0%0.053%Search for SEC Filing on Google Icon
11/16/2022Verity Asset Management Inc.31,888$1.26M1.3%N/A0.024%Search for SEC Filing on Google Icon
11/16/2022BNP Paribas Arbitrage SNC153,911$6.09M0.0%-96.1%0.114%Search for SEC Filing on Google Icon
11/15/2022Neuberger Berman Group LLC178,261$7.05M0.0%+1.7%0.132%Search for SEC Filing on Google Icon
11/15/2022Alliancebernstein L.P.912,099$36.06M0.0%-7.3%0.675%Search for SEC Filing on Google Icon
11/15/2022Castleark Management LLC216,750$8.57M0.5%+6.3%0.160%Search for SEC Filing on Google Icon
11/15/2022Pier Capital LLC172,451$6.82M1.2%N/A0.128%Search for SEC Filing on Google Icon
11/15/2022Colony Group LLC80,023$3.16M0.1%-1.6%0.059%Search for SEC Filing on Google Icon
11/15/2022Mercer Global Advisors Inc. ADV16,636$0.66M0.0%-12.0%0.012%Search for SEC Filing on Google Icon
11/15/2022Thrivent Financial for Lutherans1,317,732$52.10M0.1%-0.6%0.975%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP331,600$13.11M0.0%-15.0%0.245%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP107,139$4.24M0.0%-81.2%0.079%Search for SEC Filing on Google Icon
11/15/2022UBS Asset Management Americas Inc.519,951$20.56M0.0%+194.0%0.385%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.13,335,155$527.27M0.0%+0.3%9.862%Search for SEC Filing on Google Icon
11/15/2022Pathstone Family Office LLC5,382$0.21M0.0%-4.6%0.004%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD1,615,020$63.86M0.0%+3.3%1.194%Search for SEC Filing on Google Icon
11/15/2022Martingale Asset Management L P12,817$0.51M0.0%+145.5%0.009%Search for SEC Filing on Google Icon
11/15/2022ETF Managers Group LLC42,106$1.67M0.1%N/A0.031%Search for SEC Filing on Google Icon
11/15/2022Edgestream Partners L.P.55,732$2.20M0.2%N/A0.041%Search for SEC Filing on Google Icon
11/15/2022Federated Hermes Inc.73,841$2.92M0.0%-11.6%0.055%Search for SEC Filing on Google Icon
11/15/2022First Trust Advisors LP111,093$4.39M0.0%+38.1%0.082%Search for SEC Filing on Google Icon
11/15/2022Financial Advocates Investment Management6,421$0.54M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/15/2022First Light Asset Management LLC932,244$36.86M3.7%-1.0%0.689%Search for SEC Filing on Google Icon
11/15/2022Bayesian Capital Management LP16,100$0.64M0.1%-19.1%0.012%Search for SEC Filing on Google Icon
11/15/2022Bellevue Group AG930,500$36.79M0.5%-4.2%0.688%Search for SEC Filing on Google Icon
11/15/2022Bison Wealth LLC20,183$0.80M0.3%N/A0.015%Search for SEC Filing on Google Icon
11/14/2022United Capital Financial Advisers LLC8,995$0.36M0.0%-48.5%0.007%Search for SEC Filing on Google Icon
11/14/2022AlphaCrest Capital Management LLC10,972$0.43M0.0%-74.9%0.008%Search for SEC Filing on Google Icon
11/14/2022Macquarie Group Ltd.2,554,967$101.07M0.1%+1.4%1.890%Search for SEC Filing on Google Icon
11/14/2022Segall Bryant & Hamill LLC190,707$7.54M0.1%N/A0.141%Search for SEC Filing on Google Icon
11/14/2022Royal Bank of Canada425,952$16.84M0.0%-91.6%0.315%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Halozyme Therapeutics logo
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
Read More on Halozyme Therapeutics

Today's Range

Now: $51.84
Low: $51.82
High: $53.13

50 Day Range

MA: $54.96
Low: $50.34
High: $59.44

52 Week Range

Now: $51.84
Low: $32.00
High: $59.46

Volume

711,974 shs

Average Volume

1,304,199 shs

Market Capitalization

$7.01 billion

P/E Ratio

34.79

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Halozyme Therapeutics?

Halozyme Therapeutics' top insider shareholders include:
  1. Helen Torley (CEO)
  2. Kenneth J Kelley (Director)
  3. Michael J Labarre (SVP)
  4. Matthew L Posard (Director)
  5. Nicole Labrosse (CFO)
  6. Connie Matsui (Director)
  7. Jean-Pierre Bizzari (Director)
Learn More about top insider investors at Halozyme Therapeutics.

Who are the major institutional investors of Halozyme Therapeutics?

Halozyme Therapeutics' top institutional investors include:
  1. Stephens Investment Management Group LLC — 0.96%
  2. Tran Capital Management L.P. — 0.80%
  3. Bernzott Capital Advisors — 0.33%
  4. Redwood Investments LLC — 0.33%
  5. Fisher Asset Management LLC — 0.32%
  6. Allspring Global Investments Holdings LLC — 0.29%
Learn More about top institutional investors of Halozyme Therapeutics stock.

Which major investors are selling Halozyme Therapeutics stock?

Within the last quarter, HALO stock was sold by these institutional investors:
  1. Allspring Global Investments Holdings LLC
  2. Fisher Asset Management LLC
  3. Kornitzer Capital Management Inc. KS
  4. Bank of Montreal Can
  5. Mizuho Markets Americas LLC
  6. Tran Capital Management L.P.
  7. Los Angeles Capital Management LLC
  8. EFG Asset Management North America Corp.
In the last year, company insiders that have sold Halozyme Therapeutics company stock include:
  1. Helen Torley (CEO)
  2. Kenneth J Kelley (Director)
  3. Michael J Labarre (SVP)
  4. Matthew L Posard (Director)
Learn More investors selling Halozyme Therapeutics stock.

Which major investors are buying Halozyme Therapeutics stock?

Within the last quarter, HALO stock was acquired by institutional investors including:
  1. Lisanti Capital Growth LLC
  2. Assenagon Asset Management S.A.
  3. Pacer Advisors Inc.
  4. Arbor Investment Advisors LLC
  5. Cabot Wealth Management Inc.
  6. Pzena Investment Management LLC
  7. Birchview Capital LP
  8. Vahanian & Associates Financial Planning Inc.